Edition:
United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

1,844JPY
3:29am BST
Change (% chg)

¥25 (+1.37%)
Prev Close
¥1,819
Open
¥1,830
Day's High
¥1,854
Day's Low
¥1,830
Volume
355,900
Avg. Vol
1,178,944
52-wk High
¥1,946
52-wk Low
¥1,463

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold 20.66 March 27 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 4 4 4 4
(3) HOLD 6 6 6 6
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.73 2.73 2.73 2.73

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 1 55,700.00 55,700.00 55,700.00 --
Quarter Ending Dec-18 1 59,400.00 59,400.00 59,400.00 --
Year Ending Mar-18 10 221,325.00 224,900.00 206,000.00 211,715.00
Year Ending Mar-19 10 230,470.00 238,703.00 212,000.00 221,405.00
Earnings (per share)
Quarter Ending Sep-18 1 20.66 20.66 20.66 --
Quarter Ending Dec-18 1 21.89 21.89 21.89 --
Year Ending Mar-18 11 76.74 80.42 68.62 69.99
Year Ending Mar-19 11 74.82 83.22 60.30 76.97
LT Growth Rate (%) 2 10.33 13.27 7.40 -11.20

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 58,288.70 57,818.00 470.67 0.81
Quarter Ending Sep-17 52,350.70 54,825.00 2,474.33 4.73
Quarter Ending Jun-17 52,734.00 55,949.00 3,215.00 6.10
Quarter Ending Mar-17 51,473.00 48,429.00 3,044.00 5.91
Quarter Ending Dec-16 52,375.00 52,838.00 463.00 0.88

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 55,700.00 55,700.00 54,900.00 54,900.00 --
Quarter Ending Dec-18 59,400.00 59,400.00 58,500.00 58,500.00 --
Year Ending Mar-18 221,325.00 221,325.00 221,301.00 221,191.00 211,715.00
Year Ending Mar-19 230,470.00 230,470.00 229,787.00 229,487.00 221,405.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 1 0
Quarter Ending Dec-18 0 0 1 0
Year Ending Mar-18 0 0 1 1
Year Ending Mar-19 0 0 3 0
Earnings